| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.6 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.6 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |